complications Archives - Revista Brasileira de Ginecologia e Obstetrícia
, , , , , Summary
Rev Bras Ginecol Obstet. 2022;44(12):1102-1109
, , , , , , To evaluate the use of misoprostol prior to hysteroscopy procedures regarding technical ease, the presence of side effects, and the occurrence of complications.
This is a retrospective, observational, analytical, case-control study, with the review of medical records of 266 patients followed-up at the Gynecological Videoendoscopy Sector of the Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto of the Universidade de São Paulo (HCFMRP – USP, in the Portuguese acronym) from 2014 to 2019, comparing 133 patients who used the drug before the procedure with 133 patients who did not.
The occurrence of postmenopausal uterine bleeding was the main indication for hysteroscopy and revealed a statistical difference between groups (p < 0.001), being present in 93.23% of the patients in the study group and in 69.7% of the patients in the control group. Only 2 patients (1.5%) in the study group reported adverse effects. Although no statistical differences were observed regarding the occurrence of complications during the procedure (p = 0.0662), a higher total number of complications was noted in the group that used misoprostol (n = 7; 5.26%) compared with the group that did not use the drug (n = 1; 0.75%), a fact that is clinically relevant. When evaluating the ease of the technique (measured by the complete performance of all steps of the hysteroscopy procedure), it was verified that although there was no difference between groups (p = 0.0586), the control group had more than twice as many incompletely performed procedures (n = 17) when compared with the group that used misoprostol previously (n = 8), which is also clinically relevant.
The use of misoprostol prior to hysteroscopy in our service indicated that the drug can facilitate the performance of the procedure, but not without side effects and presenting higher complication rates.
Summary
Rev Bras Ginecol Obstet. 2022;44(12):1102-1109
, , , , , , To evaluate the use of misoprostol prior to hysteroscopy procedures regarding technical ease, the presence of side effects, and the occurrence of complications.
This is a retrospective, observational, analytical, case-control study, with the review of medical records of 266 patients followed-up at the Gynecological Videoendoscopy Sector of the Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto of the Universidade de São Paulo (HCFMRP – USP, in the Portuguese acronym) from 2014 to 2019, comparing 133 patients who used the drug before the procedure with 133 patients who did not.
The occurrence of postmenopausal uterine bleeding was the main indication for hysteroscopy and revealed a statistical difference between groups (p < 0.001), being present in 93.23% of the patients in the study group and in 69.7% of the patients in the control group. Only 2 patients (1.5%) in the study group reported adverse effects. Although no statistical differences were observed regarding the occurrence of complications during the procedure (p = 0.0662), a higher total number of complications was noted in the group that used misoprostol (n = 7; 5.26%) compared with the group that did not use the drug (n = 1; 0.75%), a fact that is clinically relevant. When evaluating the ease of the technique (measured by the complete performance of all steps of the hysteroscopy procedure), it was verified that although there was no difference between groups (p = 0.0586), the control group had more than twice as many incompletely performed procedures (n = 17) when compared with the group that used misoprostol previously (n = 8), which is also clinically relevant.
The use of misoprostol prior to hysteroscopy in our service indicated that the drug can facilitate the performance of the procedure, but not without side effects and presenting higher complication rates.
Summary
Rev Bras Ginecol Obstet. 1999;21(7):415-418
DOI 10.1590/S0100-72031999000700008
Purpose: to introduce the use of the hemostatic pack, a tampon consisting of compresses tied to the bleeding surface and left in place for 48 to 72 h and which is one of the therapeutic alternatives to be used in this situation. Patients and Methods: we evaluated 3 cases of massive bleeding during surgery, with the exchange, on average, of 1.4 blood volumes (1.2-2.4), in terms of hemostatic effectiveness of the pack and of some patient parameters such as age and amount and type of volume infused. Results: the mean age of the patients was 57 years (51, 56 and 64). Only one had been previously irradiated. The bleeding was of venous origin, from the fossa of the obturator nerve, the iliac plexus and the presacral plexus. The volume expander most often used was 0.9% physiological saline solution, followed by blood derivatives and by Ringer lactate. Two patients were submitted to ligation of the hypogastric vein during surgery, with no improvement. The use of hemostatic synthetic material was inefficient in all three cases. In one of the patients, the use of nonabsorbable sutures to close the bleeding area led to a considerable reduction of bleeding, but did not eliminate it completely. One patient died before 24 h had elapsed, with signs and symptoms of heart failure. The other two patients developed acute renal failure and one of them developed aspirative pneumonia during surgical reexploration. Conclusion: massive bleeding is related to high morbidity and mortality. Among the emergency measures used for hemostasis, the pack seems to be the most adequate.
Summary
Rev Bras Ginecol Obstet. 1999;21(7):415-418
DOI 10.1590/S0100-72031999000700008
Purpose: to introduce the use of the hemostatic pack, a tampon consisting of compresses tied to the bleeding surface and left in place for 48 to 72 h and which is one of the therapeutic alternatives to be used in this situation. Patients and Methods: we evaluated 3 cases of massive bleeding during surgery, with the exchange, on average, of 1.4 blood volumes (1.2-2.4), in terms of hemostatic effectiveness of the pack and of some patient parameters such as age and amount and type of volume infused. Results: the mean age of the patients was 57 years (51, 56 and 64). Only one had been previously irradiated. The bleeding was of venous origin, from the fossa of the obturator nerve, the iliac plexus and the presacral plexus. The volume expander most often used was 0.9% physiological saline solution, followed by blood derivatives and by Ringer lactate. Two patients were submitted to ligation of the hypogastric vein during surgery, with no improvement. The use of hemostatic synthetic material was inefficient in all three cases. In one of the patients, the use of nonabsorbable sutures to close the bleeding area led to a considerable reduction of bleeding, but did not eliminate it completely. One patient died before 24 h had elapsed, with signs and symptoms of heart failure. The other two patients developed acute renal failure and one of them developed aspirative pneumonia during surgical reexploration. Conclusion: massive bleeding is related to high morbidity and mortality. Among the emergency measures used for hemostasis, the pack seems to be the most adequate.
